Safety and acceptability of vaginal disinfection with benzalkonium chloride in HIV infected pregnant women in west Africa: ANRS 049b phase II randomized, double blinded placebo controlled trial. DITRAME Study Group.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 1758266)

Published in Sex Transm Infect on December 01, 1999

Authors

P Msellati1, N Meda, V Leroy, R Likikouët, P Van de Perre, M Cartoux, D Bonard, A Ouangre, P Combe, L Gautier-Charpentier, F Sylla-Koko, R Lassalle, M Dosso, C Welffens-Ekra, F Dabis, L Mandelbrot

Author Affiliations

1: Programme SIDA ORSTOM, Abidjan, Côte d'Ivoire.

Articles cited by this

Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA (1992) 6.99

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant. Lancet (1999) 4.11

Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. The Swedish Chlorhexidine Study Group. Lancet (1992) 2.89

Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.41

Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ (1997) 2.03

Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis (1997) 2.02

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA (1998) 2.01

Attitude of pregnant women towards HIV testing in Abidjan, Côte d'Ivoire and Bobo-Dioulasso, Burkina Faso. DITRAME Study Group (ANRS 049 Clinical Trial). Diminution de la Transmission Mère Enfant du VIH. Agence Nationale de Recherches sur le SIDA. AIDS (1998) 1.76

Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet (1996) 1.62

Therapeutic algorithms for the management of sexually transmitted diseases at the peripheral level in Côte d'Ivoire: assessment of efficacy and cost. Bull World Health Organ (1995) 1.32

Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS (1998) 1.28

Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol (1996) 1.25

Survival and disinfectant inactivation of the human immunodeficiency virus: a critical review. Rev Infect Dis (1991) 1.17

Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Côte d'Ivoire. AIDS (1998) 0.98

Inactivation of human immunodeficiency virus type 1 in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride. J Clin Microbiol (1990) 0.91

Interventions to reduce mother to child transmission of HIV. AIDS (1995) 0.91

Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins. J Pediatr (1995) 0.90

[Benzalkonium chloride tampons. Local tolerance and effects on cervix mucus]. J Gynecol Obstet Biol Reprod (Paris) (1983) 0.83

Hospital volume and survival of breast cancer patients in Connecticut. Am J Public Health (1999) 0.82

Maternal-infant transmission of HIV-1. N Engl J Med (1995) 0.78

Articles by these authors

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet (1999) 6.40

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial. Lancet (1999) 6.29

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med (1999) 6.13

The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect (2008) 5.98

Effect of serotesting with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ (1992) 5.66

Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol (2007) 4.76

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet (1999) 4.20

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mère-Enfant. Lancet (1999) 4.11

Confidential HIV testing and condom promotion in Africa. Impact on HIV and gonorrhea rates. JAMA (1992) 3.75

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23

Acceptability of voluntary HIV testing by pregnant women in developing countries: an international survey. Ghent International Working Group on Mother-to-Child Transmission of HIV. AIDS (1998) 3.11

Epidemic of fatal encephalopathy in preschool children in Burkina Faso and consumption of unripe ackee (Blighia sapida) fruit. Lancet (1999) 2.98

Sexual and reproductive life of women informed of their HIV seropositivity: a prospective cohort study in Burkina Faso. J Acquir Immune Defic Syndr (2001) 2.86

Human immunodeficiency virus infection in urban Rwanda. Demographic and behavioral correlates in a representative sample of childbearing women. JAMA (1991) 2.85

Female prostitutes: a risk group for infection with human T-cell lymphotropic virus type III. Lancet (1985) 2.84

Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet (1985) 2.77

Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics (1999) 2.69

International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV. Lancet (1998) 2.64

Postnatal transmission of HIV from mother to child. Lancet (1987) 2.60

Operational issues in preventing mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire, 1998-99. Bull World Health Organ (2001) 2.33

Prevalence of cutaneous disorders in a population of HIV-infected patients. Southwestern France, 1996. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Arch Dermatol (1998) 2.22

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology (1996) 2.22

Monitoring selective components of primary health care: methodology and community assessment of vaccination, diarrhoea, and malaria practices in Conakry, Guinea. ACSI-CCCD team. Bull World Health Organ (1989) 2.20

Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet (1993) 2.18

Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health (1993) 2.16

Tuberculosis in HIV programmes in lower-income countries: practices and risk factors. Int J Tuberc Lung Dis (2011) 2.15

Implementing family-focused HIV care and treatment: the first 2 years' experience of the mother-to-child transmission-plus program in Abidjan, Côte d'Ivoire. Trop Med Int Health (2009) 2.07

Acquired immunodeficiency syndrome in Rwanda. Lancet (1984) 2.05

Predictors of mortality among HIV-infected women in Kigali, Rwanda. Ann Intern Med (1992) 2.03

Effect of gender, age, transmission category, and antiretroviral therapy on the progression of human immunodeficiency virus infection using multistate Markov models. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Epidemiology (1998) 2.00

CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients? J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.99

Natural conception in HIV-negative women with HIV-infected partners. Lancet (1997) 1.98

Cardio- and cerebrovascular events in HIV-infected persons. AIDS (2004) 1.98

Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer (2006) 1.94

Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1993) 1.91

18-Month mortality and perinatal exposure to zidovudine in West Africa. AIDS (2001) 1.88

Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme. Bull World Health Organ (2009) 1.81

Primary infections with HIV-1 of women and their offspring in Rwanda: findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology (1997) 1.79

Attitude of pregnant women towards HIV testing in Abidjan, Côte d'Ivoire and Bobo-Dioulasso, Burkina Faso. DITRAME Study Group (ANRS 049 Clinical Trial). Diminution de la Transmission Mère Enfant du VIH. Agence Nationale de Recherches sur le SIDA. AIDS (1998) 1.76

Living with HIV: women's experience in Burkina Faso, West Africa. AIDS Care (2001) 1.73

The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost (2006) 1.72

Loss to follow-up in an international, multicentre observational study. HIV Med (2008) 1.70

Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clin Microbiol Infect (2003) 1.66

Traditional medicine in north Côte-d'Ivoire: screening of 50 medicinal plants for antibacterial activity. J Ethnopharmacol (2004) 1.62

Antibody to HTLV-III in blood donors in central Africa. Lancet (1985) 1.61

[The HIV epidemic in Burkina Faso: current status and the knowledge level of the population about AIDS, 1994-1995]. Rev Epidemiol Sante Publique (1998) 1.61

A cohort study of factors associated with failure to return for HIV post-test counselling in pregnant women: Kigali, Rwanda, 1992-1993. AIDS (1996) 1.60

Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Clin Pharmacol Ther (2008) 1.56

Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients. Antimicrob Agents Chemother (2002) 1.54

Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Obstet Gynecol (2000) 1.53

Interferon for acute hepatitis C. Cochrane Database Syst Rev (2002) 1.52

Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology. Stat Med (2001) 1.50

Congenital diaphragmatic hernia: can prenatal ultrasonography predict outcome? Am J Obstet Gynecol (1996) 1.47

[Pheochromocytoma and pregnancy. Case report]. Gynecol Obstet Fertil (2006) 1.45

Male circumcision, sexually transmitted disease, and risk of HIV. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.45

Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med (2002) 1.44

Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. Pregnancy and HIV Study Group. AIDS (1998) 1.42

[Seroprevalence of viral hepatitis C in patients with human immunodeficiency virus infection]. Presse Med (1992) 1.42

Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer (1998) 1.41

Surveillance of heterosexually acquired HIV infection and AIDS. Lancet (1995) 1.40

Infant feeding policy and practice in the presence of HIV-1 infection. AIDS (1995) 1.39

Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests. Gastroenterol Clin Biol (2008) 1.39

Heterosexual promiscuity among African patients with AIDS. N Engl J Med (1985) 1.38